Conning Inc’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35.5M | Buy |
163,437
+6,523
| +4% | +$1.45M | 1.18% | 28 |
|
|
2025
Q4 | $35.9M | Sell |
156,914
-9,167
| -6% | -$2.09M | 1.2% | 9 |
|
|
2025
Q3 | $38.5M | Sell |
166,081
-24,942
| -13% | -$5.08M | 1.28% | 6 |
|
|
2025
Q2 | $35.5M | Buy |
191,023
+12,690
| +7% | +$2.36M | 1.22% | 24 |
|
|
2025
Q1 | $37.4M | Sell |
178,333
-42,567
| -19% | -$8.28M | 1.31% | 11 |
|
|
2024
Q4 | $39.3M | Buy |
220,900
+18,638
| +9% | +$3.43M | 1.38% | 5 |
|
|
2024
Q3 | $39.9M | Sell |
202,262
-28,123
| -12% | -$5.25M | 1.32% | 17 |
|
|
2024
Q2 | $39.5M | Buy |
230,385
+6,927
| +3% | +$1.15M | 1.42% | 7 |
|
|
2024
Q1 | $40.6M | Sell |
223,458
-19,288
| -8% | -$3.32M | 1.33% | 14 |
|
|
2023
Q4 | $37.5M | Sell |
242,746
-9,330
| -4% | -$1.36M | 1.31% | 11 |
|
|
2023
Q3 | $37.5M | Sell |
252,076
-18,421
| -7% | -$2.7M | 1.37% | 5 |
|
|
2023
Q2 | $36.4M | Buy |
270,497
+21,436
| +9% | +$3.14M | 1.22% | 24 |
|
|
2023
Q1 | $39.6M | Buy |
249,061
+5,003
| +2% | +$765K | 1.33% | 9 |
|
|
2022
Q4 | $39.4M | Sell |
244,058
-28,851
| -11% | -$4.42M | 1.28% | 9 |
|
|
2022
Q3 | $36.6M | Sell |
272,909
-39,804
| -13% | -$5.71M | 1.3% | 9 |
|
|
2022
Q2 | $47.9M | Buy |
312,713
+294,343
| +1,602% | +$45M | 1.43% | 5 |
|
|
2022
Q1 | $2.98M | Buy |
18,370
+72
| +0.4% | +$10.5K | 0.08% | 148 |
|
|
2021
Q4 | $2.48M | Sell |
18,298
-1,440
| -7% | -$170K | 0.07% | 144 |
|
|
2021
Q3 | $2.13M | Sell |
19,738
-2,067
| -9% | -$236K | 0.06% | 153 |
|
|
2021
Q2 | $2.46M | Sell |
21,805
-1,195
| -5% | -$135K | 0.07% | 141 |
|
|
2021
Q1 | $2.49M | Sell |
23,000
-2,090
| -8% | -$224K | 0.07% | 138 |
|
|
2020
Q4 | $2.69M | Sell |
25,090
-840
| -3% | -$80.7K | 0.09% | 130 |
|
|
2020
Q3 | $2.27M | Buy |
25,930
+310
| +1% | +$29.2K | 0.08% | 135 |
|
|
2020
Q2 | $2.52M | Buy |
25,620
+2,717
| +12% | +$239K | 0.09% | 123 |
|
|
2020
Q1 | $1.75M | Sell |
22,903
-274
| -1% | -$23.3K | 0.07% | 136 |
|
|
2019
Q4 | $2.05M | Sell |
23,177
-69,072
| -75% | -$5.73M | 0.07% | 144 |
|
|
2019
Q3 | $6.99M | Sell |
92,249
-70
| -0.1% | -$4.8K | 0.24% | 75 |
|
|
2019
Q2 | $6.71M | Sell |
92,319
-474,549
| -84% | -$37.3M | 0.22% | 80 |
|
|
2019
Q1 | $45.7M | Buy |
566,868
+71,309
| +14% | +$5.83M | 1.43% | 18 |
|
|
2018
Q4 | $45.7M | Sell |
495,559
-8,333
| -2% | -$733K | 1.55% | 10 |
|
|
2018
Q3 | $47.7M | Buy |
503,892
+40,481
| +9% | +$3.84M | 1.41% | 16 |
|
|
2018
Q2 | $42.9M | Buy |
463,411
+69,982
| +18% | +$6.83M | 1.31% | 23 |
|
|
2018
Q1 | $37.2M | Buy |
393,429
+247,545
| +170% | +$27.2M | 1.2% | 35 |
|
|
2017
Q4 | $14.1M | Buy |
145,884
+93,090
| +176% | +$8.77M | 0.47% | 62 |
|
|
2017
Q3 | $4.69M | Sell |
52,794
-340
| -0.6% | -$25.9K | 0.16% | 107 |
|
|
2017
Q2 | $3.85M | Sell |
53,134
-658
| -1% | -$44.2K | 0.14% | 125 |
|
|
2017
Q1 | $3.5M | Sell |
53,792
-2,630
| -5% | -$165K | 0.13% | 128 |
|
|
2016
Q4 | $3.53M | Sell |
56,422
-92,045
| -62% | -$5.62M | 0.14% | 125 |
|
|
2016
Q3 | $9.36M | Sell |
148,467
-327,311
| -69% | -$21.2M | 0.37% | 66 |
|
|
2016
Q2 | $29.5M | Sell |
475,778
-42,270
| -8% | -$2.58M | 1.22% | 23 |
|
|
2016
Q1 | $29.6M | Sell |
518,048
-549
| -0.1% | -$30.6K | 1.24% | 24 |
|
|
2015
Q4 | $30.7M | Buy |
518,597
+36,282
| +8% | +$2.09M | 1.31% | 19 |
|
|
2015
Q3 | $26.2M | Buy |
482,315
+20,143
| +4% | +$1.31M | 1.15% | 31 |
|
|
2015
Q2 | $31.1M | Sell |
462,172
-9,661
| -2% | -$631K | 1.27% | 15 |
|
|
2015
Q1 | $27.6M | Buy |
471,833
+118,673
| +34% | +$7.17M | 1.17% | 32 |
|
|
2014
Q4 | $23.1M | Sell |
353,160
-49,633
| -12% | -$3.13M | 1.13% | 26 |
|
|
2014
Q3 | $23.3M | Buy |
402,793
+30,901
| +8% | +$1.72M | 1.22% | 20 |
|
|
2014
Q2 | $21M | Sell |
371,892
-616
| -0.2% | -$32.3K | 1.12% | 24 |
|
|
2014
Q1 | $19.1M | Buy |
372,508
+4,109
| +1% | +$208K | 1.12% | 24 |
|
|
2013
Q4 | $19.5M | Buy |
368,399
+59,072
| +19% | +$2.9M | 1.21% | 18 |
|
|
2013
Q3 | $13.8M | Buy |
309,327
+5,148
| +2% | +$228K | 1.07% | 26 |
|
|
2013
Q2 | $12.6M | Buy |
+304,179
| New | +$13.3M | 1.04% | 29 |
|
Other funds holding ABBV
VCM
VPM
Conning Inc's ABBV Position: Q1 2026 in Review
Conning Inc increased its AbbVie (ABBV) stake by 4.2% in Q1 2026, buying an estimated $1.45M and bringing the position to 163,437 shares worth $35.5M. The position accounts for 1.18% of the portfolio, ranked #28.
Conning Inc first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $47.9M in Q2 2022. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Conning Inc held 163,437 shares of AbbVie worth $35.5M as of Q1 2026.
- Conning Inc bought 6,523 AbbVie shares in Q1 2026, an estimated $1.45M.
- AbbVie made up 1.18% of Conning Inc's portfolio in Q1 2026, its #28 holding.
- Conning Inc first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Conning Inc's AbbVie position peaked at $47.9M in Q2 2022.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Conning Inc's 13F filing for Q1 2026, filed 30 Apr 2026.